TIC stock news
This page provides real-time market news, earnings updates, and company announcements related to TIC Solutions, Inc. (TIC).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-17 07:37 EST
Ocular Therapeutix to Announce Topline Data for SOL-1 Phase 3 Superiority Trial in Wet AMD on Tuesday, February 17, 2026
Finviz2026-02-13 22:03:02
Ocular Therapeutix Reports Positive Results from Landmark SOL-1 Phase 3 Superiority Trial in Wet AMD
Finviz2026-02-17 12:03:44
JPMorgan Initiates TIC Solutions (TIC) Highlighting NV5 Integration and Cross-Selling Synergies
Finviz2026-02-19 00:45:38
February 20 Member Morning Report: Nvidia Previews "Explosive" New Chip; U.S. Records Huge Trade Deficit in December
华尔街见闻2026-02-19 23:11:40
Ocular Therapeutix to Present Detailed SOL-1 Data at the 49th Macula Society Annual Meeting and Host Investor Webcast to Discuss Presentations
Finviz2026-02-23 12:03:47
Ocular Therapeutix to Participate in March Investor Conferences
Finviz2026-02-24 12:03:59
Ocular Therapeutix to Participate in March Investor Conferences
Finviz2026-02-24 12:03:59
Safe Pro to Demonstrate Integrated AI Capabilities on General Dynamics Mission Systems' GeoSuite at U.S. Army TiC 2.0 Event at Fort Hood, Texas
Finviz2026-02-24 13:12:12
TIC Solutions, Inc. (TIC): A Bull Case Theory
Finviz2026-02-28 15:27:51
Cricut, Inc. (CRCT) Q4 Earnings Match Estimates
Finviz2026-03-03 23:27:36
Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-03-09 20:06:47
Safe Pro Completes Latest U.S. Army Transforming in Contact 2.0 Exercise at Fort Hood, Texas
Finviz2026-03-17 12:06:54
Ocular Therapeutix to Present Additional SOL-1 Data and Analyses at Upcoming Scientific Conferences in April
Finviz2026-04-01 11:03:12
Ocular Therapeutix Announces Additional Positive Week 52 Data from Landmark SOL-1 Phase 3 Trial of AXPAXLI in Wet AMD
Finviz2026-04-13 11:03:46
Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-04-14 11:03:56
Ocular Therapeutix to Present Detailed SOL-1 Data at the 49th Macula Society Annual Meeting and Host Investor Webcast to Discuss Presentations
Finviz2026-02-23 12:03:47
Ocular Therapeutix to Participate in March Investor Conferences
Finviz2026-02-24 12:03:59
Ocular Therapeutix to Participate in March Investor Conferences
Finviz2026-02-24 12:03:59
Safe Pro to Demonstrate Integrated AI Capabilities on General Dynamics Mission Systems' GeoSuite at U.S. Army TiC 2.0 Event at Fort Hood, Texas
Finviz2026-02-24 13:12:12
TIC Solutions, Inc. (TIC): A Bull Case Theory
Finviz2026-02-28 15:27:51
Cricut, Inc. (CRCT) Q4 Earnings Match Estimates
Finviz2026-03-03 23:27:36
Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-03-09 20:06:47
Safe Pro Completes Latest U.S. Army Transforming in Contact 2.0 Exercise at Fort Hood, Texas
Finviz2026-03-17 12:06:54
Ocular Therapeutix to Present Additional SOL-1 Data and Analyses at Upcoming Scientific Conferences in April
Finviz2026-04-01 11:03:12
Ocular Therapeutix Announces Additional Positive Week 52 Data from Landmark SOL-1 Phase 3 Trial of AXPAXLI in Wet AMD
Finviz2026-04-13 11:03:46
Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-04-14 11:03:56
TIC stock chart
TIC stock detailsTIC stock price change
On the last trading day, TIC stock closed at 7.64 USD, with a price change of -3.66% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more